BD's Q4 Revenues Increase 10 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Becton Dickinson today reported that its fourth-quarter revenues increased 10 percent year over year with growth across all segments aided by currency effects.

The Franklin Lakes, NJ-based maker of medical, research, and diagnostic products recorded total revenues of $2.05 billion for the fourth quarter ended Sept. 30, compared to revenues of $1.87 billion for Q4 2010. On a currency-neutral basis its revenues rose 4 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.